“Cochlear researches, develops and sells cochlear implants for severely hearing-impaired individuals around the world. Founded in 1981 and based in Sydney, Australia, the company has cumulatively provi”
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.
